CopyPastehas never been so tasty!

The Pharmaceutical Market : Malaysia

by anonymous

  • 0
  • 0
  • 0
62 views

OVERVIEW OF THE PHARMACEUTICAL MARKET IN MALAYSIA

The macroenvironment will be defined by an increase in GDP and population during the forecast period. Politically, the government aims to reduce its fiscal deficit, following a recent period of fiscal stimulus and loose monetary policy. Economically, Malaysia will be the tenth largest economy in the Asia Pacific region covered by Espicom in 2017. In terms of GDP per capita, Malaysia will rank eighth. Legally, Malaysia remained on the US Trade Representative’s (USTR) Watch List in 2011, despite the government strengthening its IPR protection and enforcement. Demographically, the population is estimated to have a high growth rate. By 2017, the EIU projects that the population of Malaysia will be the 11th largest in the Asia Pacific region. The elderly population is expected to grow in the forecast period. Malaysia has a largely young population, with those aged between 0-14 years old making up nearly a third of the total. http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/the-pharmaceutical-market-malaysia.html

The Malaysian pharmaceutical market is small and relies heavily on the import of medicaments. Espicom projects the market to grow at a low double-digit CAGR in US dollar terms during the forecast period. However, it will remain as the fifth smallest pharmaceutical market in the Asia Pacific region in size terms by 2017. There are around 250 Malaysian pharmaceutical manufacturers licensed by the Drug Control Authority, although over two-thirds of these are traditional medicine manufacturers. There is little multinational manufacturing activity in the country due to strict regulations, although these may be relaxed in the future. Ranbaxy and GSK are the only examples of large global multinational companies that have manufacturing operations in the country. Malaysia is heavily dependent on the imports of retail medicaments, which represent around three-quarters of total imports. As most pharmaceutical manufacturing is for local consumption, the balance of pharmaceutical trade will remain considerably negative, and the deficit is likely to increase in the forecast period.

The government has identified biotechnology as one of the core technologies to accelerate the transformation of Malaysia into a knowledge-based economy and an industrialised nation by year 2020. The Malaysian Biotechnology Corporation (BiotechCorp) is the leading agency responsible for the co-ordinated implementation of the National Biotechnology Policy (NBP). The most important Malaysian biologic manufacturers include Bioven, CCM Duopharma, Inno Biologics and Ninebio. The National Pharmaceutical Control Bureau (NPCB) has adopted the Guidance Document and Guidelines for the Registration of Biosimilars, making Malaysia only the second country, after Australia, in the Asia Pacific region to adopt regulations for biosimilar registration. There have been a number of competitive strategies completed over the last 18 months: Agila Specialities has agreed to establish a biopharmaceuticals facility at Bio-XCell park; US-based Viropro has acquired Alpha Biologics; and Indian-based Avesthage, in partnership with Inno Biologics, has manufactured clinical grade darbepoetin alfa, its biosimilar version of Amgen’s Aranesp.

PROVIDING STRATEGIC MARKET ANALYSIS EVERY MONTH
Espicom's highly-regarded world pharmaceutical market research reports provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Market size and trends impacting the development of the market.
Five-year projections for market indicators such as health spending.
Regulations on drug applications & approvals, pricing & reimbursement as well as wholesaling and retail.
Specialised intelligence on generics and biological medicines.
Foreign and local company profiles

EXECUTIVE SUMMARY...... 1
Snapshot: Strategic Espicom Analysis.....2
Snapshot: Key Data Projections.3
MACROENVIRONMENT .... 4
POLITICAL....4
ECONOMIC..5
Projections....5
LEGAL....6
Counterfeit Drugs7
DEMOGRAPHIC.8
Projections....8
Current Figures ...8
Demographic Indicators...9
Births.. 9
Deaths...... 9
Infant Deaths.. 9
Life Expectancy at Birth.... 9
EPIDEMIOLOGY. 10
DISEASE BURDEN...10
Leading Causes of Mortality..10
DISEASE PREVALENCE..11
Communicable Diseases.11
HIV/AIDS. 11
Non-Communicable Diseases......12
Cancer..... 12
Diabetes. 12
HEALTHCARE - ACCOMPANYING HEALTH STATISTICS.. 13
ORGANISATION......13
Public Sector......13
US$55.0 Million National Cancer Institute ..... 13
Private Sector.....13
EXPENDITURE..14
Projections..14
Latest Figures.....15
Ninth Development Plan Allocation.. 15
INFRASTRUCTURE..16
Hospital Infrastructure...16
Outpatient Infrastructure......17
SERVICES....18
Inpatient Analysis.....18
Outpatient Analysis.19
WORKFORCE... 20
Projections..20
Latest Figures.....21
REGULATORY AFFAIRS... 22
INTERNATIONAL AUTHORITY.. 22
NATIONAL AUTHORITIES... 22
Drug Control Authority...22
National Pharmaceutical Control Bureau 22
MARKETING REGISTRATION..... 23
Pharmaceutical Registration Process.23
Bioequivalence Studies for Pharmaceutical Registration23
Priority or Queue System24
Licensing24
Pharmaceutical Labelling .....24
Registration of NCEs.24
Registration of Generics..25
Registration of Traditional Medicines & OTCs25
Drug Applications & Regulations25
Good Manufacturing Practice......26
Clinical Trials......26
MADRAC (ADR Reporting).....26
PROMOTION....26
Advertising .26
PRICING & REIMBURSEMENT 27
PRICING......27
DISTRIBUTION CHANNELS.... 28
DRUG WHOLESALING.. 28
Selected Wholesalers......28
Apex Healthcare.28
DKSH Malaysia....29
Pharmaniaga29
Zuellig Pharma....29
DRUG RETAILING... 29
Selected Pharmacy Chains....29
Guardian Pharmacy..29
Watsons Malaysia......29
MARKET ANALYSIS... 30
SIZE..... 30
Projections..30
Historical Figures......32
Current Size.33
PRODUCT DEVELOPMENT..33
MANUFACTURING. 34
Government Strategies for the Local Industry, 2006-2020..35
TRADE 36
Exports.36
Imports.39
Balance of Trade43
COMPETITION....44
TRADE ASSOCIATIONS 44
MOPI44
PhAMA....45
COMPANY INTELLIGENCE.. 46
Domestic Manufacturers46
Ain Medicare46
Carotech.46
SM Pharmaceuticals..46
Multinational Manufacturers46
Atlantic Laboratories46
Ranbaxy Malaysia.....46
OTC PHARMACEUTICALS 47
COMPETITION..47
Company Intelligence.....47
Chemical Company of Malaysia Pharmaceuticals 47
GSK Malaysia 47
IDS Manufacturing.... 47
Winwa Medical ... 47
YSP Industries..... 47
GENERIC PHARMACEUTICALS.....48
COMPETITION. 48
Company Intelligence.....48
Chemical Company of Malaysia Pharmaceuticals48
Dynapharm..48
Getz Pharma Malaysia.....48
Hovid ......49
Kotra Pharma......49
Pharmaniaga49
Sunward Pharmaceutical49
Xepa-Soul Pattison....49
BIOLOGICS & BIOSIMILARS .. 50
REGULATION... 50
MARKET SIZE... 50
RESEARCH & DEVELOPMENT....51
Bio-XCell. 51
COMPETITION..52
Trade Fair.....52
BioMalaysia 201152
Company Intelligence.....52
Actis Biologics .... 52
Alpha Biologics... 52
Bioven..... 52
CCM Duopharma 53
Emergent Biosolutions.... 53
Getz Pharma Malaysia..... 53
Inno Biologics .....54
Magna Mission....54
Malladi Drugs & Pharmaceutical Ltd.54
Ninebio...54
Saamya Biotech..55
Stemlife..55
Vivo Bio Tech55
Competitive Strategies...56
CONCLUSIONS: OPPORTUNITIES & CHALLENGES.. 57
Strategic Espicom Analysis.57
MACROENVIRONMENT....57
EPIDEMIOLOGY..57
HEALTHCARE......58
REGULATORY AFFAIRS.....58
PRICING & REIMBURSEMENT.59
DISTRIBUTION CHANNELS.....59
MARKET59
COMPETITION ....60
OTC PHARMACEUTICALS.60
GENERIC PHARMACEUTICALS60
BIOLOGICS & BIOSIMILARS....61
Radar Analysis 63
SWOT Analysis 63
DIRECTORY.64
GOVERNMENT ORGANISATIONS.... 64
PHARMACEUTICAL COMPANIES..... 64
Foreign Pharmaceutical Companies...64
Local Pharmaceutical Companies64
TRADE ORGANISATIONS.... 64\

For more information kindly visit :
The Pharmaceutical Market : Malaysia

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/BharatBook
Our Blogs: http://in.linkedin.com/pub/bharat-book/3a/98/512
http://financemarketreports.blogspot.com/

Add A Comment: